Telix Pharmaceuticals Earnings Estimate

By analyzing Telix Pharmaceuticals' earnings estimates, investors can diagnose different trends across Telix Pharmaceuticals' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Telix Pharmaceuticals Limited is based on EPS before non-recurring items and includes expenses related to employee stock options. Telix Pharmaceuticals is projected to generate 0.0744 in earnings per share on the 31st of December 2025. Telix Pharmaceuticals earnings estimates show analyst consensus about projected Telix Pharmaceuticals Limited EPS (Earning Per Share). It derives the highest and the lowest estimates based on Telix Pharmaceuticals' historical volatility. Many public companies, such as Telix Pharmaceuticals, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Telix Pharmaceuticals Revenue Breakdown by Earning Segment

By analyzing Telix Pharmaceuticals' earnings estimates, investors can diagnose different trends across Telix Pharmaceuticals' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to rise to about 323.9 M in 2024. Pretax Profit Margin is likely to rise to 0.01 in 2024Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.